RTG 300 (Potiga 300 mg)
Generic Name: ezogabine
Pill with imprint RTG 300 is Green, Elliptical / Oval and has been identified as Potiga 300 mg. It is supplied by GlaxoSmithKline.
Potiga is used in the treatment of epilepsy; seizures and belongs to the drug class neuronal potassium channel openers. Risk cannot be ruled out during pregnancy. Potiga 300 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
Images for RTG 300
Potiga
- Generic Name
- ezogabine
- Imprint
- RTG 300
- Strength
- 300 mg
- Color
- Green
- Size
- 16.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Neuronal potassium channel openers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 5 - Some potential for abuse
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- 00173-0813
- Inactive Ingredients
-
croscarmellose sodium, FD&C Blue No. 2, hypromelloses, ferric oxide yellow, soya lecithin, magnesium stearate, microcrystalline cellulose, polyvinyl alcohol, magnesium silicate, titanium dioxide, xanthan gum
Note: Inactive ingredients may vary.
More about Potiga (ezogabine)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Drug class: neuronal potassium channel openers
- FDA Alerts (3)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
